Achieving low-density lipoprotein cholesterol treatment goals among dyslipidemic individuals in the Levant: The CEntralized Pan-Levant survey on the Undertreatment of hypercholeSterolemia (CEPHEUS) study

Current Medical Research and Opinion

Volumn 30, Issue 10, 2014, Pages 1957-1965

  Hammoudeh, Ayman J ^a   Echtay, Akram ^b   Ghanem, Georges Y ^c   Haddad, Jihad ^a  

^a Istishari Hospital Amman   (Jordan)

^b LEBANESE UNIVERSITY   (Lebanon)

^c RIZK HOSPITAL   (Lebanon)

Author keywords

Cardiovascular diseases; Low density lipoprotein cholesterol; Statins; Treatment goals

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DRUG EFFICACY; DYSLIPIDEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GOAL ATTAINMENT; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METABOLIC SYNDROME X; MIDDLE AGED; MONOTHERAPY; MULTICENTER STUDY; PHYSICIAN; PRACTICE GUIDELINE; PRIMARY PREVENTION; QUESTIONNAIRE; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; SMOKING; WAIST CIRCUMFERENCE; AGED; BLOOD; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; DYSLIPIDEMIAS; INCIDENCE; LEBANON; OUTCOME ASSESSMENT; TREATMENT FAILURE;

AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPOLIPIDEMIC AGENTS; INCIDENCE; LEBANON; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUESTIONNAIRES; RISK FACTORS; TREATMENT FAILURE;

EID: 84925258972     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2014.929095     Document Type: Article

References (32)

1. DaarA.S. SingerP.A. PersadD.L.et alGrand challenges in chronic non-communicable diseases.Nature2007450494-6
2. McQueenM.J. HawkenS. WangX.et alLipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study.Lancet2008372224-33
3. FranklinK. GoldbergR.J. SpencerF. et al.Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary EventsArch Intern Med20041641457-1463
4. HammoudehA.J. Al-TarawnehH. ElharassisA. et al.Prevalence of conventional risk factors in Jordanians with coronary heart disease: The Jordan Hyperlipidemia and Related Targets Study (JoHARTS)Int J Cardiol2006110179-183
5. HammoudehA.J. HamdanH. IzraiqM.et alImpact of diabetes mellitus on short- and long-term prognosis in >5500 Middle Eastern patients with acute coronary syndrome.Eur Heart J200930Suppl919
6. AlirezaE. MehrshadA. ManouchehrN.et alPrevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome.Cardiovascular Diabetology2006515-20
7. RamachandranA. MaR.C. SnehalathaC.Diabetes in AsiaLancet2010375408-418
8. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.Lancet20023607-22
9. SeverP.S. DahlofB. PoulterN.R.et alPrevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.Lancet20033611149-58
10. Di AngelantonioE. SarwarN. PerryP. et al.Major lipids, apolipoproteins, and risk of vascular diseaseJAMA20093021993-2000
11. ReinerZ. CatapanoA.L. De BackerG. et al.ESC/EAS guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)Eur Heart J2011321769-1818
12. FordE.S. MokdadA.H. GilesW.H. MensahG.A.Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: Findings from the National Health and Nutrition Examination Survey, 1999 to 2000Circulation20031072185-2189
13. EUROASPIRE II Euro Heart Survey Programme InvestigatorsLifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.Eur Heart J200122554-72
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsThird Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.Circulation20021063143-421
15. De BackerG. AmbrosioniE. Borch-JohnsenK. et al.European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)Atherosclerosis2004173381-391
16. De BackerG. AmbrosioniE. Borch-JohnsenK.et alEuropean guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).Eur J Cardiovasc Prev Rehabil200310S1-10
17. MottilloS. FilionK.B. GenestJ.et alThe metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.J Am Coll Cardiol2010561113-32
18. BrugtsJ.J. YetginT. HoeksS.E.et alThe benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials.BMJ2009338b2376
19. PearsonT.A. LauroraI. ChuH. KafonekS.The lipid treatment assessment project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goalsArch Intern Med2000160459-467
20. GrundyS.M. CleemanJ.I. MerzC.N. et al.Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelinesCirculation2004110227-239
21. HermansM.P. Castro CabezasM. StrandbergT. et al.Centralized Pan-European survey on the under-treatment of hypercholesterolaemia (CEPHEUS): Overall findings from eight countriesCurr Med Res Opin201026445-454
22. FerrieresJ. GousseE.T. FabryC. HermansM.P.Assessment of lipid-lowering treatment in France - the CEPHEUS study.Arch Cardiovasc Dis2008101557-63
23. ParkJ.E. ChiangC.E. MunawarM.et alLipid-lowering treatment in hypercholesterolaemic patients: the CEPHEUS Pan-Asian survey.Eur J Prev Cardiol201219781-94
24. ArafahM.R. Al MahmeedW.A.The undertreatment of hypercholesterolemia in Saudi Arabia and the Gulf States: results of the CEPHEUS study.Circulation2011124A12727
25. StoneN.J. RobinsonJ. LichtensteinA.H.et al2013ACC/AHA guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Circulation2013published online 12 November 201310.1161/01.cir.0000437738.63853.7a
26. Garcia RuizF.J. Marin IbanezA. Perez-JimenezF.et alCurrent lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.Pharmacoeconomics200422Suppl 31-12
27. ReinerZ. SonickiZ. Tedeschi-ReinerE.Public perceptions of cardiovascular risk factors in Croatia: The PERCRO surveyPrev Med201051494-496
28. ReinerZ. SonickiZ. Tedeschi-ReinerE.Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: the PERCRO-DOC survey.Atherosclerosis2010213598-603
29. WoodD.A. KotsevaK. ConnollyS. et al.Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: A paired, cluster-randomised controlled trialLancet20083711999-2012
30. SlossE.M. SolomonD.H. ShekelleP.G. et al.Selecting target conditions for quality of care improvement in vulnerable older adultsJ Am Geriatr Soc200048363-369
31. BaigentC. BlackwellL. EmbersonJ.et alEfficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.Lancet20103761670-81
32. McKenneyJ.M. DavidsonM.H. JacobsonT.A. GuytonJ.R.Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.Am J Cardiol20069789-94C